ProKidney Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-151.61	-163.34	-135.45	-148.14	-55.15
Depreciation & Amortization	6.58	5.43	3.85	3.04	1.98
Stock-Based Compensation	25.34	29.37	30.85	74.47	0.7
Other Adjustments	-1.7	-1.78	-6	-	-
Changes in Other Operating Activities	1.28	3.96	16.67	-6.46	2.16
Operating Cash Flow	-120.12	-126.35	-90.07	-77.09	-50.3
Capital Expenditures	-15.2	-29.51	-34.2	-1.85	-5.19
Sale of Property, Plant & Equipment	18.22	-	-	-	0
Purchases of Investments	-217.08	-324.02	-471.6	-	-
Proceeds from Sale of Investments	318.02	373.95	175.82	-	-
Other Investing Activities	-	-	-	0.11	-
Investing Cash Flow	103.97	20.41	-329.98	-1.74	-5.19
Long-Term Debt Issued	-	-	-	35	-
Long-Term Debt Repaid	-	-	-	-35	-
Issuance of Common Stock	25.6	144.46	-	542.5	-
Repurchase of Common Stock	-	-	-9.5	-	-
Net Common Stock Issued (Repurchased)	25.6	144.46	-9.5	542.5	-
Other Financing Activities	-0.03	-0.05	-0.05	6.02	71.47
Financing Cash Flow	25.57	144.41	-9.55	548.52	71.47
Net Cash Flow	9.42	38.47	-429.6	469.69	15.98
Free Cash Flow	-135.31	-155.86	-124.27	-78.94	-55.49
FCF Margin	-15152.63%	-205078.95%	-	-	-
Free Cash Flow Per Share	-1.01	-1.59	-2.01	-1.28	-0.37
Levered Free Cash Flow	-76.33	-81.31	-49.14	-113.3	-56.19
Unlevered Free Cash Flow	-172.8	-203.13	-172.21	-159.21	-56.19

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q